Skip to main content
Top
Published in: Critical Care 4/2012

Open Access 01-08-2012 | Research

Therapeutic and toxic blood concentrations of nearly 1,000 drugs and other xenobiotics

Authors: Martin Schulz, Stefanie Iwersen-Bergmann, Hilke Andresen, Achim Schmoldt

Published in: Critical Care | Issue 4/2012

Login to get access

Abstract

Introduction

In order to assess the significance of drug levels measured in intensive care medicine, clinical and forensic toxicology, as well as for therapeutic drug monitoring, it is essential that a comprehensive collection of data is readily available. Therefore, it makes sense to offer a carefully referenced compilation of therapeutic and toxic plasma concentration ranges, as well as half-lives, of a large number of drugs and other xenobiotics for quick and comprehensive information.

Methods

Data have been abstracted from original papers and text books, as well as from previous compilations, and have been completed with data collected in our own forensic and clinical toxicology laboratory. The data presented in the table and corresponding annotations have been developed over the past 20 years and longer. A previous compilation has been completely revised and updated. In addition, more than 170 substances, especially drugs that have been introduced to the market since 2003 as well as illegal drugs, which became known to cause intoxications, were added. All data were carefully referenced and more than 200 new references were included. Moreover, the annotations providing details were completely revised and more than 100 annotations were added.

Results

For nearly 1,000 drugs and other xenobiotics, therapeutic ("normal") and, if data were available, toxic and comatose-fatal blood-plasma concentrations and elimination half-lives were compiled in a table.

Conclusions

In case of intoxications, the concentration of the ingested substances and/or metabolites in blood plasma better predicts the clinical severity of the case when compared to the assumed amount and time of ingestion. Comparing and contrasting the clinical case against the data provided, including the half-life, may support the decision for or against further intensive care. In addition, the data provided are useful for the therapeutic monitoring of pharmacotherapies, to facilitate the diagnostic assessment and monitoring of acute and chronic intoxications, and to support forensic and clinical expert opinions.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bronstein AC, Spyker DA, Cantilena LR Jr, Green JL, Rumack BH, Dart RC: 2010 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 28th Annual Report. Clin Toxicol (Phila) 2011, 49: 910-941. 10.3109/15563650.2011.635149CrossRef Bronstein AC, Spyker DA, Cantilena LR Jr, Green JL, Rumack BH, Dart RC: 2010 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 28th Annual Report. Clin Toxicol (Phila) 2011, 49: 910-941. 10.3109/15563650.2011.635149CrossRef
2.
go back to reference Marraffa JM, Cohen V, Howland MA: Antidotes for toxicological emergencies: a practical review. Am J Health Syst Pharm 2012, 69: 199-212. 10.2146/ajhp110014PubMedCrossRef Marraffa JM, Cohen V, Howland MA: Antidotes for toxicological emergencies: a practical review. Am J Health Syst Pharm 2012, 69: 199-212. 10.2146/ajhp110014PubMedCrossRef
4.
go back to reference Schulz M, Schmoldt A: Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics. Pharmazie 2003, 58: 447-474.PubMed Schulz M, Schmoldt A: Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics. Pharmazie 2003, 58: 447-474.PubMed
5.
go back to reference Baselt RC: Disposition of Toxic Drugs and Chemicals in Man. 9th edition. Seal Beach: Biomedical Publications; 2011. Baselt RC: Disposition of Toxic Drugs and Chemicals in Man. 9th edition. Seal Beach: Biomedical Publications; 2011.
6.
go back to reference Deom A: L'intoxication d'origine inconnue, l'apport du laboratoire pour le clinicien. Ther Umsch 1986, 43: 259-268.PubMed Deom A: L'intoxication d'origine inconnue, l'apport du laboratoire pour le clinicien. Ther Umsch 1986, 43: 259-268.PubMed
7.
go back to reference Deom A: Valeurs usuelles des taus sanguins, urinaires et autres lors de traitements ou lors d'intoxications chez l'homme. Ther Umsch 1986, 43: 261-268. Deom A: Valeurs usuelles des taus sanguins, urinaires et autres lors de traitements ou lors d'intoxications chez l'homme. Ther Umsch 1986, 43: 261-268.
8.
go back to reference Dollery C: Therapeutic Drugs. Edinburgh: Churchill Livingstone; 1991. Dollery C: Therapeutic Drugs. Edinburgh: Churchill Livingstone; 1991.
9.
go back to reference Drayer DE: Pharmacologically active drug metabolites: therapeutic and toxic activities, plasma and urine data in man, accumulation in renal failure. Clin Pharmacokinet 1976, 1: 426-443. 10.2165/00003088-197601060-00003PubMedCrossRef Drayer DE: Pharmacologically active drug metabolites: therapeutic and toxic activities, plasma and urine data in man, accumulation in renal failure. Clin Pharmacokinet 1976, 1: 426-443. 10.2165/00003088-197601060-00003PubMedCrossRef
10.
go back to reference Drayer DE: Problems in therapeutic drug monitoring: the dilemma of enantiomeric drugs in man. Ther Drug Monit 1988, 10: 1-7.PubMedCrossRef Drayer DE: Problems in therapeutic drug monitoring: the dilemma of enantiomeric drugs in man. Ther Drug Monit 1988, 10: 1-7.PubMedCrossRef
11.
go back to reference Druid H, Holmgren P: A compilation of fatal and control concentrations of drugs in postmortem femoral blood. J Forensic Sci 1997, 42: 79-87.PubMedCrossRef Druid H, Holmgren P: A compilation of fatal and control concentrations of drugs in postmortem femoral blood. J Forensic Sci 1997, 42: 79-87.PubMedCrossRef
12.
go back to reference DRUGDEX® System Greenwood Village, CO, USA: Thomson Reuters (Healthcare) Inc. Updated periodically; DRUGDEX® System Greenwood Village, CO, USA: Thomson Reuters (Healthcare) Inc. Updated periodically;
13.
go back to reference Hiemke C, Baumann P, Bergemann N, Conca A, Dietmaier O, Egberts K, Fric M, Gerlach M, Greiner C, Gründer G, Haen E, Havemann-Reinecke U, Jaquenoud Sirot E, Kirchherr H, Laux G, Lutz UC, Messer T, Müller MJ, Pfuhlmann B, Rambeck B, Riederer P, Schoppek B, Stingl J, Uhr M, Ulrich S, Waschgler R, Zernig G: AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011. Pharmacopsychiatry 2011, 44: 195-235.CrossRef Hiemke C, Baumann P, Bergemann N, Conca A, Dietmaier O, Egberts K, Fric M, Gerlach M, Greiner C, Gründer G, Haen E, Havemann-Reinecke U, Jaquenoud Sirot E, Kirchherr H, Laux G, Lutz UC, Messer T, Müller MJ, Pfuhlmann B, Rambeck B, Riederer P, Schoppek B, Stingl J, Uhr M, Ulrich S, Waschgler R, Zernig G: AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011. Pharmacopsychiatry 2011, 44: 195-235.CrossRef
14.
go back to reference Kirsten R, Nelson K, Kirsten D, Heintz B: Clinical pharmacokinetics of vasodilators. Part I. Clin Pharmacokinet 1998, 34: 457-482. 10.2165/00003088-199834060-00003PubMedCrossRef Kirsten R, Nelson K, Kirsten D, Heintz B: Clinical pharmacokinetics of vasodilators. Part I. Clin Pharmacokinet 1998, 34: 457-482. 10.2165/00003088-199834060-00003PubMedCrossRef
15.
go back to reference Kirsten R, Nelson K, Kirsten D, Heintz B: Clinical pharmacokinetics of vasodilators. Part II. Clin Pharmacokinet 1998, 35: 9-36. 10.2165/00003088-199835010-00002PubMedCrossRef Kirsten R, Nelson K, Kirsten D, Heintz B: Clinical pharmacokinetics of vasodilators. Part II. Clin Pharmacokinet 1998, 35: 9-36. 10.2165/00003088-199835010-00002PubMedCrossRef
16.
go back to reference Meyer FP: Indicative therapeutic and toxic drug concentrations in plasma: a tabulation. Int J Clin Pharmacol Ther 1994, 32: 71-81.PubMed Meyer FP: Indicative therapeutic and toxic drug concentrations in plasma: a tabulation. Int J Clin Pharmacol Ther 1994, 32: 71-81.PubMed
17.
go back to reference Moffat AC, Jackson JV, Moss MS, Widdop B: Clarke's Isolation and Identification of Drugs in Pharmaceuticals, Body Fluids, and Post-Mortem Material. 2nd edition. London: Pharmaceutical Press; 1986. Moffat AC, Jackson JV, Moss MS, Widdop B: Clarke's Isolation and Identification of Drugs in Pharmaceuticals, Body Fluids, and Post-Mortem Material. 2nd edition. London: Pharmaceutical Press; 1986.
18.
go back to reference Pentz B, Strubelt O, Gehlhoff C: Therapeutische, toxische und letale Arzneimittelkonzentrationen im menschlichen Plasma. Dt Ärztebl 1979, 43: 2815-2820. Pentz B, Strubelt O, Gehlhoff C: Therapeutische, toxische und letale Arzneimittelkonzentrationen im menschlichen Plasma. Dt Ärztebl 1979, 43: 2815-2820.
19.
go back to reference Regenthal R, Krüger M, Köppel C, Preiß R: Zu Möglichkeiten und Grenzen von therapeutischen und klinisch-toxikologischen Referenzwerten für Plasma-/Serum-/Vollblutkonzentrationen von Arzneimitteln bei akuten Vergiftungen - eine Übersicht. Anästhesiol Intensivmed 1999, 40: 129-144. Regenthal R, Krüger M, Köppel C, Preiß R: Zu Möglichkeiten und Grenzen von therapeutischen und klinisch-toxikologischen Referenzwerten für Plasma-/Serum-/Vollblutkonzentrationen von Arzneimitteln bei akuten Vergiftungen - eine Übersicht. Anästhesiol Intensivmed 1999, 40: 129-144.
20.
go back to reference Repetto MR, Repetto M: Therapeutic, toxic, and lethal concentrations in human fluids of 90 drugs affecting the cardiovascular and hematopoietic systems. J Toxicol Clin Toxicol 1997, 35: 345-351. 10.3109/15563659709043365PubMedCrossRef Repetto MR, Repetto M: Therapeutic, toxic, and lethal concentrations in human fluids of 90 drugs affecting the cardiovascular and hematopoietic systems. J Toxicol Clin Toxicol 1997, 35: 345-351. 10.3109/15563659709043365PubMedCrossRef
21.
go back to reference Repetto MR, Repetto M: Habitual, toxic, and lethal concentrations of 103 drugs of abuse in humans. J Toxicol Clin Toxicol 1997, 35: 1-9. 10.3109/15563659709001158PubMedCrossRef Repetto MR, Repetto M: Habitual, toxic, and lethal concentrations of 103 drugs of abuse in humans. J Toxicol Clin Toxicol 1997, 35: 1-9. 10.3109/15563659709001158PubMedCrossRef
22.
go back to reference Repetto MR, Repetto M: Therapeutic, toxic, and lethal concentrations of 73 drugs affecting respiratory system in human fluids. J Toxicol Clin Toxicol 1998, 36: 287-293. 10.3109/15563659809028023PubMedCrossRef Repetto MR, Repetto M: Therapeutic, toxic, and lethal concentrations of 73 drugs affecting respiratory system in human fluids. J Toxicol Clin Toxicol 1998, 36: 287-293. 10.3109/15563659809028023PubMedCrossRef
23.
go back to reference Repetto MR, Repetto M: Concentrations in human fluids: 101 drugs affecting the digestive system and metabolism. J Toxicol Clin Toxicol 1999, 37: 1-9.PubMedCrossRef Repetto MR, Repetto M: Concentrations in human fluids: 101 drugs affecting the digestive system and metabolism. J Toxicol Clin Toxicol 1999, 37: 1-9.PubMedCrossRef
24.
go back to reference Stead AH, Moffat AC: A collection of therapeutic, toxic and fatal blood drug concentrations in man. Hum Toxicol 1983, 2: 437-464. 10.1177/096032718300200301PubMedCrossRef Stead AH, Moffat AC: A collection of therapeutic, toxic and fatal blood drug concentrations in man. Hum Toxicol 1983, 2: 437-464. 10.1177/096032718300200301PubMedCrossRef
25.
go back to reference Uges DRA: Orientierende Angaben zu therapeutischen und toxischen Konzentrationen von Arzneimitteln und Giften in Blut, Serum oder Urin. Weinheim: VCH; 1990. Uges DRA: Orientierende Angaben zu therapeutischen und toxischen Konzentrationen von Arzneimitteln und Giften in Blut, Serum oder Urin. Weinheim: VCH; 1990.
26.
go back to reference USP DI® Volume I: Drug Information for the Health Care Professional. 26th edition. Greenwood Village, CO, USA: Thomson Reuters (Healthcare) Inc; 2006. USP DI® Volume I: Drug Information for the Health Care Professional. 26th edition. Greenwood Village, CO, USA: Thomson Reuters (Healthcare) Inc; 2006.
27.
go back to reference Neels HM, Sierens AC, Naelaerts K, Scharpe SL, Hatfield GM, Lambert WE: Therapeutic drug monitoring of old and newer anti-epileptic drugs. Clin Chem Lab Med 2004, 42: 1228-1255.PubMedCrossRef Neels HM, Sierens AC, Naelaerts K, Scharpe SL, Hatfield GM, Lambert WE: Therapeutic drug monitoring of old and newer anti-epileptic drugs. Clin Chem Lab Med 2004, 42: 1228-1255.PubMedCrossRef
28.
go back to reference Regenthal R, Krueger M, Koeppel C, Preiss R: Drug levels: therapeutic and toxic serum/plasma concentrations of common drugs. J Clin Monit Comput 1999, 15: 529-544. 10.1023/A:1009935116877PubMedCrossRef Regenthal R, Krueger M, Koeppel C, Preiss R: Drug levels: therapeutic and toxic serum/plasma concentrations of common drugs. J Clin Monit Comput 1999, 15: 529-544. 10.1023/A:1009935116877PubMedCrossRef
29.
go back to reference Winek CL, Wahba WW, Winek CL Jr, Balzer TW: Drug and chemical blood-level data 2001. Forensic Sci Int 2001, 122: 107-123. 10.1016/S0379-0738(01)00483-2PubMedCrossRef Winek CL, Wahba WW, Winek CL Jr, Balzer TW: Drug and chemical blood-level data 2001. Forensic Sci Int 2001, 122: 107-123. 10.1016/S0379-0738(01)00483-2PubMedCrossRef
30.
go back to reference Musshoff F, Padosch S, Steinborn S, Madea B: Fatal blood and tissue concentrations of more than 200 drugs. Forensic Sci Int 2004, 142: 161-210. 10.1016/j.forsciint.2004.02.017PubMedCrossRef Musshoff F, Padosch S, Steinborn S, Madea B: Fatal blood and tissue concentrations of more than 200 drugs. Forensic Sci Int 2004, 142: 161-210. 10.1016/j.forsciint.2004.02.017PubMedCrossRef
Metadata
Title
Therapeutic and toxic blood concentrations of nearly 1,000 drugs and other xenobiotics
Authors
Martin Schulz
Stefanie Iwersen-Bergmann
Hilke Andresen
Achim Schmoldt
Publication date
01-08-2012
Publisher
BioMed Central
Published in
Critical Care / Issue 4/2012
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc11441

Other articles of this Issue 4/2012

Critical Care 4/2012 Go to the issue